首页> 美国卫生研究院文献>Archives of Disease in Childhood. Fetal and Neonatal Edition >Antenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in very low birthweight infants
【2h】

Antenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in very low birthweight infants

机译:出生前的类固醇与出生时体重很轻的婴儿脑白质损害的发生率降低有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aims: To investigate whether antenatal steroids reduce the incidence of cerebral white matter lesions in very low birthweight infants. Methods: A total of 224 newborn infants of < 31 weeks gestational age and weighing < 1500 g was studied between January 1998 and June 2000. Obstetric and neonatal information was obtained from the case notes. The study population was subdivided into two groups according to antenatal steroid exposure. A complete course of treatment consisted of two doses of 12 mg each of betamethasone given at an interval of 12–24 hours. Infants in group 1 were born to mothers who had not received betamethasone, or were delivered within 24 hours of receiving the first dose of steroid. Infants in group 2 were born to mothers who had received one or more complete courses of betamethasone and were delivered > 24 hours after receiving the first dose of steroid. Results: The two groups contained statistically similar proportions of boys and girls, and the infants had similar birth weights and survival rates. Those in group 2, compared with those in group 1, had a lower gestational age (p = 0.02) and a lower incidence of white matter lesions on cranial ultrasound scans (p = 0.03). Stepwise logistic regression analysis showed that gestational age (p = 0.0002) and a complete course of antenatal steroids (p = 0.02) had independent effects on cerebral white matter lesions. Conclusions: These observations suggest that a complete course of antenatal steroids may have a protective effect against cerebral white matter lesions in very low birthweight infants.
机译:目的:研究出生前类固醇是否能降低极低出生体重儿脑白质损害的发生率。方法:从1998年1月至2000年6月,共研究了224个胎龄小于31周且体重小于1500 g的新生儿。从病例记录中获得了产科和新生儿信息。根据产前类固醇暴露,将研究人群分为两组。一个完整的治疗过程包括两次服用12 mg的倍他米松,每次间隔12-24小时。第一组的婴儿是未接受倍他米松的母亲所生,或在接受第一剂类固醇的24小时内分娩。第2组婴儿是由接受了一个或多个完整疗程倍他米松的母亲所生,并在接受第一剂类固醇激素后24小时内分娩。结果:两组在统计学上男女比例相似,婴儿的出生体重和存活率相似。与第1组相比,第2组患者的胎龄较低(p = 0.02),颅脑超声扫描中白质病变的发生率较低(p = 0.03)。逐步logistic回归分析显示,胎龄(p = 0.0002)和完整疗程的产前类固醇(p = 0.02)对脑白质病变具有独立的影响。结论:这些观察结果表明,一整疗程的类固醇激素可能对极低出生体重的婴儿的脑白质损害具有保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号